Meaghann S Weaver1,2, Bryce B Reeve3,4, Justin N Baker1, Christa E Martens3, Molly McFatrich3, Catriona Mowbray2, Diana Palma5, Lillian Sung6,7, Deborah Tomlinson6, Janice Withycombe8,9, Pamela Hinds10,11. 1. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Oncology, Children's National Health Systems, Washington, DC. 3. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. 4. Department of Health Policy and Management, Gillings School of Global Public Health, Chapel Hill, North Carolina. 5. Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California. 6. Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, Canada. 7. Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Canada. 8. Palmetto Health Children's Hospital, Columbia, South Carolina. 9. Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia. 10. Department of Nursing Research and Quality Outcomes, Children's National Health Systems, Washington, DC. 11. Department of Pediatrics, George Washington University, Washington, DC.
Abstract
BACKGROUND: Symptoms arising from disease or treatment are subjective experiences. Insight into pediatric oncology treatment side effects or symptoms is ideally obtained from direct inquiry to the ill child. A concept-elicitation phase in a patient-reported outcome (PRO) instrument design provides an opportunity to elicit children's voices to shape cancer symptom selection and terminology. METHODS: Through semistructured, one-on-one, voice-recorded interviews, symptom data were collected from 96 children with cancer between the ages of 7 and 20 years who were undergoing oncologic treatment at 7 pediatric oncology sites in the United States and Canada. RESULTS: The mean number of symptoms reported per child over the prior 7 days was 1.49 (range, 0-7; median, 1; standard deviation, 1.56). The most common symptoms across all age groups were tiredness or fatigue, nausea or vomiting, aches or pains, and weakness. There was not a statistically significant correlation between self-reported wellness and the number of reported symptoms (r = -0.156, n = 65, P = .215) or the number of symptoms reported by age group or diagnosis type. Forty participants reported experiencing a change in their body in the past week, with one-third of these changes unanticipated. Only through direct questions about feelings were emotional symptoms revealed because 90.6% of interviewees who discussed feelings (48 of 53) did so only in the context of direct questioning on feelings. Adolescents were more likely than younger children to discuss feelings as part of the interview. CONCLUSIONS: Concept elicitation from children and adolescents has the potential to enable researchers to develop age-appropriate, accurately representative PRO measures.
BACKGROUND: Symptoms arising from disease or treatment are subjective experiences. Insight into pediatric oncology treatment side effects or symptoms is ideally obtained from direct inquiry to the ill child. A concept-elicitation phase in a patient-reported outcome (PRO) instrument design provides an opportunity to elicit children's voices to shape cancer symptom selection and terminology. METHODS: Through semistructured, one-on-one, voice-recorded interviews, symptom data were collected from 96 children with cancer between the ages of 7 and 20 years who were undergoing oncologic treatment at 7 pediatric oncology sites in the United States and Canada. RESULTS: The mean number of symptoms reported per child over the prior 7 days was 1.49 (range, 0-7; median, 1; standard deviation, 1.56). The most common symptoms across all age groups were tiredness or fatigue, nausea or vomiting, aches or pains, and weakness. There was not a statistically significant correlation between self-reported wellness and the number of reported symptoms (r = -0.156, n = 65, P = .215) or the number of symptoms reported by age group or diagnosis type. Forty participants reported experiencing a change in their body in the past week, with one-third of these changes unanticipated. Only through direct questions about feelings were emotional symptoms revealed because 90.6% of interviewees who discussed feelings (48 of 53) did so only in the context of direct questioning on feelings. Adolescents were more likely than younger children to discuss feelings as part of the interview. CONCLUSIONS: Concept elicitation from children and adolescents has the potential to enable researchers to develop age-appropriate, accurately representative PRO measures.
Authors: Louis S Matza; Donald L Patrick; Anne W Riley; John J Alexander; Luis Rajmil; Andreas M Pleil; Monika Bullinger Journal: Value Health Date: 2013-06 Impact factor: 5.725
Authors: Elizabeth Ward; Carol DeSantis; Anthony Robbins; Betsy Kohler; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2014-01-31 Impact factor: 508.702
Authors: Eivor A Laugsand; Mirjam A G Sprangers; Kristin Bjordal; Frank Skorpen; Stein Kaasa; Pål Klepstad Journal: Health Qual Life Outcomes Date: 2010-09-21 Impact factor: 3.186
Authors: Bryce B Reeve; Janice S Withycombe; Justin N Baker; Mary C Hooke; Jessica C Lyons; Catriona Mowbray; Jichuan Wang; David R Freyer; Steven Joffe; Lillian Sung; Deborah Tomlinson; Stuart H Gold; Pamela S Hinds Journal: Pediatr Blood Cancer Date: 2013-01-17 Impact factor: 3.167
Authors: Ethan Basch; Xiaoyu Jia; Glenn Heller; Allison Barz; Laura Sit; Michael Fruscione; Mark Appawu; Alexia Iasonos; Thomas Atkinson; Shari Goldfarb; Ann Culkin; Mark G Kris; Deborah Schrag Journal: J Natl Cancer Inst Date: 2009-11-17 Impact factor: 13.506
Authors: Debra E Irwin; Heather E Gross; Brian D Stucky; David Thissen; Esi Morgan DeWitt; Jin Shei Lai; Dagmar Amtmann; Leyla Khastou; James W Varni; Darren A DeWalt Journal: Health Qual Life Outcomes Date: 2012-02-22 Impact factor: 3.186
Authors: Luis Rajmil; Amanda Rodríguez López; Sílvia López-Aguilà; Jordi Alonso Journal: Health Qual Life Outcomes Date: 2013-06-20 Impact factor: 3.186
Authors: Flora Tzelepis; Shiho K Rose; Robert W Sanson-Fisher; Tara Clinton-McHarg; Mariko L Carey; Christine L Paul Journal: BMC Cancer Date: 2014-01-25 Impact factor: 4.430
Authors: Meaghann S Weaver; Abby R Rosenberg; Julia Tager; Christopher S Wichman; Lori Wiener Journal: J Palliat Med Date: 2017-11-27 Impact factor: 2.947
Authors: Bryce B Reeve; Molly McFatrich; Jennifer W Mack; Scott H Maurer; Shana S Jacobs; David R Freyer; Janice S Withycombe; Justin N Baker; Sharon M Castellino; Li Lin; Nicole R Lucas; Pamela S Hinds Journal: J Natl Cancer Inst Date: 2020-11-01 Impact factor: 13.506
Authors: Meaghann S Weaver; Jichuan Wang; Katie A Greenzang; Molly McFatrich; Pamela S Hinds Journal: Support Care Cancer Date: 2021-10-18 Impact factor: 3.603
Authors: David R Freyer; Li Lin; Jennifer W Mack; Scott H Maurer; Molly McFatrich; Justin N Baker; Shana S Jacobs; Nicole Lucas; Janice S Withycombe; Deborah Tomlinson; Katie Rose Villabroza; Mia K Waldron; Pamela S Hinds; Bryce B Reeve Journal: J Clin Oncol Date: 2022-03-16 Impact factor: 50.717
Authors: Bryce B Reeve; Molly McFatrich; Laura C Pinheiro; Meaghann S Weaver; Lillian Sung; Janice S Withycombe; Justin N Baker; Jennifer W Mack; Mia K Waldron; Deborah Gibson; Deborah Tomlinson; David R Freyer; Catriona Mowbray; Shana Jacobs; Diana Palma; Christa E Martens; Stuart H Gold; Kathryn D Jackson; Pamela S Hinds Journal: Pediatr Blood Cancer Date: 2016-09-21 Impact factor: 3.167
Authors: Eve Namisango; Katherine Bristowe; Matthew J Allsop; Fliss E M Murtagh; Melanie Abas; Irene J Higginson; Julia Downing; Richard Harding Journal: Patient Date: 2019-02 Impact factor: 3.883
Authors: Bryce B Reeve; Molly McFatrich; Li Lin; Nicole R Lucas; Jennifer W Mack; Shana S Jacobs; Janice S Withycombe; Justin N Baker; David R Freyer; Pamela S Hinds Journal: Cancer Date: 2020-12-17 Impact factor: 6.860
Authors: Allison Barz Leahy; Lisa A Schwartz; Yimei Li; Bryce B Reeve; Justin E Bekelman; Richard Aplenc; Ethan M Basch Journal: Cancer Date: 2021-05-04 Impact factor: 6.921
Authors: Pamela S Hinds; Meaghann S Weaver; Janice S Withycombe; Justin N Baker; Shana S Jacobs; Jennifer W Mack; Scott H Maurer; Molly McFatrich; Laura C Pinheiro; Bryce B Reeve; Jichuan Wang Journal: J Pain Symptom Manage Date: 2020-10-20 Impact factor: 5.576